摘要
本文对欧洲五国(德、英、法、意、西)的药品定价模式进行概览,并比较这些国家对新药及仿制药施行的不同定价方法,如效益评估、内部参考定价、国际参考定价等,同时介绍了这些国家的主要药品费用控制措施和最新医改动向。
This article gives an overview of the drug pricing systems in the EU5 countries (Germany, UK, France, Italy and Spain), and benchmarks different pricing methods for new drugs and generics such as benefit evaluation, internal referencing and international referencing. It also introduces the key cost containment measures as well as provides updates on the latest health care reforms in these countries.
出处
《中国医疗保险》
2011年第8期55-57,共3页
China Health Insurance
关键词
欧洲
药品定价
医改
费用控制
仿制药
europe, health care reforms, drug pricing, cost containment, generics